Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 125.60
Bid: 125.40
Ask: 125.80
Change: 2.20 (1.78%)
Spread: 0.40 (0.319%)
Open: 123.20
High: 125.60
Low: 123.20
Prev. Close: 123.40
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results of Placing

21 Mar 2013 12:00

RNS Number : 5442A
HICL Infrastructure Company Ld
21 March 2013
 



HICL Infrastructure Company Limited

21 March 2013

Not for publication, release of distribution in whole or in part in Australia, Canada, South Africa, Japan or the United States

 

Preliminary Results of Placing, Open Offer and Offer for Subscription of New Ordinary Shares

The Board of HICL Infrastructure Company Limited ("HICL") is pleased to announce that the Placing, Open Offer and Offer for Subscription of New Ordinary Shares (the 'Issue') has now closed and that, on the basis of applications received through the Open Offer and Offer for Subscription and of orders taken through the Placing, both the Issue's target size of 100 million Ordinary Shares (raising gross proceeds of £119.5 million) and its maximum potential size of 140 million Ordinary Shares (raising gross proceeds of £167.3 million) have been comfortably exceeded.

In accordance with the terms and conditions of the Issue, all applications made pursuant to Open Offer entitlements will be met in full. The Board is, in conjunction with its advisers, considering the basis upon which applications made pursuant to the Placing, the Offer for Subscription and (to the extent it is relevant) the Excess Application Facility should be scaled back given the high level of oversubscription in respect of the Issue.

The Board has consulted with the Investment Adviser, InfraRed Capital Partners Limited, on the Additional Investments which would allow the size of the Issue to be increased. As a result, the Board has decided that the overall size of the Issue will be set at its maximum of 140 million New Ordinary Shares.

A further announcement providing details of the basis upon which New Ordinary Shares will be allotted will be made on Friday 22 March 2013.

For further information, please contact: 

InfraRed Capital Partners Limited

Tony Roper

Keith Pickard

Robin Hubbard

David Foot

Erwan Fournis

 

+44 (0) 20 7484 1800

Canaccord Genuity Limited

David Yovichic

Lucy Lewis

Robbie Robertson

 

+44 (0) 20 7523 8000

Tulchan Communications

Ed Orlebar

 

+44 (0) 20 7353 4200

Dexion Capital (Guernsey) Limited

Gillian Newton

+44 (0) 1481 732814

Terms in this announcement shall have the same meaning as defined in the prospectus issued by HICL dated 26 February 2013.

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for the Company and for no one else in connection with the Issue and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Canaccord Genuity Limited or for affording advice in relation to the Issue, or any other matters referred to herein.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJBMLTMBTTMJJ
Date   Source Headline
24th Nov 20217:00 amRNSInterim Results 6 Months Ended 30th September 2021
24th Nov 20217:00 amRNSPublication of Interim Report
17th Nov 20217:00 amRNSSecond Quarterly Interim Dividend
8th Nov 20217:00 amRNSAcquisition Activity
27th Oct 20217:00 amRNSNotice of Interim Results
13th Oct 20217:00 amRNSTransaction Activity
30th Sep 20217:00 amRNSChair Succession
27th Jul 20217:00 amRNSInterim Update Statement
21st Jul 202111:51 amRNSFirst Quarterly Interim Dividend
20th Jul 202112:00 pmRNSResult of AGM
13th Jul 202112:00 pmRNSAnnual General Meeting Details
9th Jul 20217:00 amRNSHICL signs first PPP LIBOR transition
9th Jun 20217:00 amRNSNotice of AGM
1st Jun 20217:00 amRNSPublication of HICL's 2021 Sustainability Report
26th May 20217:00 amRNSPublication of Annual Report
26th May 20217:00 amRNSAnnual Results for the year ended 31 March 2021
24th May 20217:00 amRNSHICL secures £400m ESG-linked SONIA facility
19th May 20213:15 pmRNSFourth Quarterly Interim Dividend
22nd Apr 20217:00 amRNSNotice of Annual Results
2nd Mar 20213:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20213:19 pmRNSDirector/PDMR Shareholding
1st Mar 20217:00 amRNSDisposal of an investment
23rd Feb 20217:00 amRNSInterim Update Statement
17th Feb 20213:00 pmRNSThird Quarterly Interim Dividend
25th Nov 20207:01 amRNSPublication of Interim Report
25th Nov 20207:00 amRNSInterim Results Six Months Ended 30 September 2020
23rd Nov 20207:00 amRNSNew Long-dated Letter of Credit Facility
18th Nov 20203:00 pmRNSSecond Quarterly Interim Dividend
28th Oct 20207:00 amRNSNotice of Interim Results
9th Sep 20204:14 pmRNSHolding(s) in Company
14th Aug 20209:45 amRNSKepler Trust Intelligence: New Research
31st Jul 20207:00 amRNSTotal Voting Rights
22nd Jul 20203:00 pmRNSDirector/PDMR Shareholding
21st Jul 20203:08 pmRNSResult of Placing
21st Jul 20207:00 amRNSIncremental Acquisition
16th Jul 20207:00 amRNSInterim Update Statement
16th Jul 20207:00 amRNSProposed issue of equity
15th Jul 202011:25 amRNSFirst Quarterly Interim Dividend
14th Jul 202011:23 amRNSResult of AGM
12th Jun 202011:36 amRNSAnnual General Meeting Circular
10th Jun 202010:26 amRNSNew Investments
4th Jun 20202:05 pmRNSDirector Declaration
20th May 20207:01 amRNSPublication of Annual Report
20th May 20207:00 amRNSAnnual Financial Report
13th May 20203:00 pmRNSFourth Quarterly Interim Dividend
6th May 20207:00 amRNSNotice of Annual Results
28th Apr 20205:30 pmRNSDisclosure of Rights Attached to Equity Shares
27th Mar 202010:35 amRNSDirector/PDMR Shareholding
23rd Mar 20202:49 pmRNSDirector/PDMR Shareholding
20th Mar 20204:18 pmRNSUpdate and Investor Call

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.